TMS Coverage by Major Insurance Providers in 2026: A State-by-State Guide

Everything you need to know about TMS Coverage by Major Insurance Providers in 2026: A State-by-State Guide — how it works, what it costs, and how to find a provider who actually knows what they're doing.

Insurance coverage for TMS has expanded significantly since the FDA cleared it for treatment-resistant depression in 2008. What once required significant out-of-pocket spending is now covered by most major insurers, though the details vary considerably by carrier, plan type, and state regulations. Understanding how insurance works for TMS helps you plan financially and advocate effectively for the treatment you need.

What You’ll Learn

• Which major insurers cover TMS and under what conditions
• Medicare and Medicaid coverage rules by state
• Common reasons for insurance denials and how to address them
• The prior authorization process and timeline
• How to file an appeal if your TMS is denied
• Strategies for reducing or eliminating out-of-pocket costs

How Insurance Typically Covers TMS

Most health insurance plans cover TMS for treatment-resistant depression, following FDA clearance and growing clinical evidence of efficacy. Coverage requires meeting specific criteria, typically involving:

• A diagnosis of major depressive disorder
• Failure of a specified number of antidepressant trials (usually 2-4 depending on the insurer)
• Often, a trial of psychotherapy first
• Treatment provided by an in-network provider using FDA-cleared equipment

The criteria exist because insurers want evidence that TMS is medically necessary for your specific case, not just a preference. Successfully getting coverage means demonstrating that you meet these criteria through documentation from your treating provider.

Coverage by Major Insurance Carriers

Aetna

Aetna covers TMS for treatment-resistant depression when patients have failed at least 4 antidepressant trials from at least 2 different drug classes. They also require documentation that the depression is significantly impairing function despite these treatments.

Aetna does not require prior authorization for standard TMS protocols, but they do require it for high-frequency protocols and certain device types. Their coverage extends to both standard rTMS and theta burst stimulation when clinically appropriate.

Blue Cross Blue Shield

BCBS plans vary by state and specific plan type. Most cover TMS for treatment-resistant depression with requirements similar to other carriers: 1-3 prior antidepressant failures, documented functional impairment, and in-network provider use.

BCBS plans tend to have relatively straightforward coverage once you meet initial criteria. They are generally considered one of the more reliable insurers for TMS coverage. However, always verify specifics with your plan, as state-level variations can be significant.

Cigna

Cigna covers TMS for patients who have failed at least 2 antidepressants from different drug classes. They require prior authorization for all TMS requests. Cigna has been expanding coverage in recent years and now covers more protocols than they did 3-4 years ago.

Cigna has a specific TMS network of providers who have been credentialed for TMS treatment. Using an in-network TMS specialist simplifies the prior authorization process and reduces the risk of coverage issues.

UnitedHealthcare

UnitedHealthcare covers TMS for treatment-resistant depression with requirements of at least 2 failed antidepressant trials. They have expanded coverage to include theta burst stimulation protocols. Prior authorization is required.

UnitedHealthcare has been known to have somewhat aggressive utilization management, meaning they may request additional documentation or second opinions more frequently than other carriers. Having thorough documentation from your provider helps navigate this process.

Kaiser Permanente

Kaiser covers TMS in regions where they have TMS equipment and trained providers. Their coverage requires meeting standard criteria for treatment-resistant depression. However, TMS availability is limited to Kaiser facilities that have the equipment, which may mean traveling to a specific medical center.

If you are a Kaiser member, check whether your local Kaiser facility offers TMS. If not, ask about referrals to community providers under your plan.

Medicare Coverage

Medicare Part B covers TMS as a physician-administered outpatient procedure. Medicare covers TMS for treatment-resistant depression with typical requirements of 4 failed antidepressant trials or treatment intolerance.

The coverage applies to the physician fees and the facility fees. Medicare beneficiaries typically pay 20% of the Medicare-approved amount after meeting the Part B deductible. For standard TMS, this means out-of-pocket costs of approximately $200-400 per session before supplemental insurance.

Medigap plans typically cover the 20% co-insurance, making TMS effectively free for beneficiaries with good supplemental coverage. Medicare Advantage plans have their own coverage rules, which vary by plan.

Medicaid Coverage

Medicaid coverage for TMS varies significantly by state. Some states cover TMS through their Medicaid programs, while others do not due to budget constraints or policy choices.

States with robust Medicaid TMS coverage include California, New York, Massachusetts, and several Northeast states. Coverage requirements vary but typically align with Medicare criteria: documented treatment-resistant depression and failure of multiple medication trials.

To determine your state’s Medicaid coverage for TMS, contact your state Medicaid office or ask your provider’s billing department, as they typically know which states cover TMS and what documentation is required.

Prior Authorization Process

Most insurance plans require prior authorization for TMS. Your provider submits clinical documentation demonstrating that you meet coverage criteria, including your diagnosis, medication history, and functional impairment.

The prior authorization process typically takes 1-2 weeks. Some insurers process requests faster, while others may take longer if they request additional information. Your provider’s office should track this and follow up if the timeline exceeds expectations.

If prior authorization is approved, you can schedule treatment knowing your insurance will cover it. If denied, you have the right to appeal.

Common Denial Reasons and How to Address Them

Not Meeting Medication Trial Requirements

The most common denial reason is insufficient documentation of prior antidepressant trials. Insurers want specific evidence: drug names, doses, duration of trials, and reasons for discontinuation. Vague references to trying “several medications” are not sufficient.

Solution: Request your medical records documenting each trial. Work with your provider to submit complete documentation including exact drug names, doses, dates, and reasons for discontinuation or switching. If you had a genuine reason for not trying certain medications (intolerance, contraindication), document that clearly.

Incomplete Clinical Documentation

Insurers may deny TMS if the clinical documentation does not adequately describe your functional impairment, the severity of your depression, or the failure of other treatments.

Solution: Ensure your provider’s prior authorization submission includes PHQ-9 or similar depression scale scores, descriptions of how depression affects work, relationships, and daily functioning, and evidence that depression persists despite treatment.

Not Using an In-Network Provider

Some plans only cover TMS from in-network providers. Going out of network can result in full denial or significantly higher patient responsibility.

Solution: Verify provider network status before scheduling treatment. Ask the TMS clinic to confirm they are in-network for your specific plan before starting.

Protocol Not Covered

Some insurers only cover standard rTMS protocols and do not cover theta burst or other accelerated protocols.

Solution: If you need a specific protocol, have your provider document the medical necessity for that protocol rather than standard rTMS. If coverage is denied, file an appeal with clinical justification.

Filing an Appeal

If your TMS is denied, you have the right to appeal. Most insurers have a three-level appeal process: internal appeal, external review, and potentially judicial review.

Gather documentation to support your appeal. Include letters from your treating psychiatrist explaining why TMS is medically necessary, documentation of medication trials and therapy attempts, evidence of functional impairment (time off work, disability claims, inability to maintain relationships), and any research or clinical guidelines supporting TMS for your specific case.

Insurers often reverse denials on appeal, especially when additional documentation clarifies why treatment is necessary. Do not assume the denial is final without attempting an appeal.

Reducing Out-of-Pocket Costs

Several strategies can reduce what you pay for TMS:

Use in-network providers: In-network providers have negotiated rates that reduce patient responsibility.

Verify benefits before treatment: Call your insurer and verify exact coverage, including co-pay per session, any deductible requirements, and out-of-pocket maximums.

Check for financial assistance programs: Some device manufacturers offer patient assistance programs. Some clinics offer sliding scale fees or payment plans.

Consider theta burst protocols: Shorter treatment sessions may reduce facility fees, depending on your plan’s billing structure.

Use supplemental insurance: If you have Medicare, a Medigap policy can cover most of your out-of-pocket costs.

Finding a Provider Who Handles Insurance

The TMS List directory includes providers who accept major insurance plans. Search by your insurance carrier and location to find providers who are in-network for your specific plan. Many clinics have billing specialists who help verify insurance coverage and navigate the prior authorization process before you commit to treatment.

Do not let insurance complexity stop you from pursuing TMS. The coverage process is navigable with proper documentation and persistence. Many patients who initially faced denials have successfully appealed and received coverage for this effective treatment.